Percent of high-risk persons (e.g., COPD) age 18-64 who received an influenza vaccination in the past 12 months

Measure Source

Healthy People 2010, measure 14-29c.

National Table

1.87a Percent of high-risk persons age 18-64 who received an influenza vaccination in the past 12 months, United States, 1999 and 2003.

National Data Source

Centers for Disease Control and Prevention, National Center for Health Statistics, National Health Interview Survey (NHIS).

National Denominator

U.S. population: high-risk adults age 18-64.

National Numerator

A subset of denominator who report receiving an influenza vaccination in the past 12 months.

State Table

1.87b Percent of high-risk persons age 18-64 who received an influenza vaccination in the past 12 months, by State, 2001 and 2003.

State Data Source

Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Behavioral Risk Factor Surveillance System (BRFSS).

State Denominator

Number of high-risk persons age 18-64.

State Numerator

Number of high-risk persons age 18-64 who answered "Yes" to the question "During the past 12 months, have you had a flu shot?"

Comments

High-risk conditions include diabetes, heart disease, lung disease, kidney disease, liver disease, and cancer. Not all high-risk conditions for complications of influenza and pneumococcal disease can be ascertained by NHIS (e.g., immunocompromised), and the sample size may be too small for some groups.

Percents are age-adjusted to the 2000 standard population. Age-adjusted percents are weighted sums of age-specific percents. For a discussion of age adjustment, see Part A, Section 5 of Tracking Healthy People 2010.

Race categories have changed since 2001. Data for 2001 and later years may not be comparable to data from previous years.

Return to Contents

Percent of persons age 65 and over who received an influenza vaccination in the past 12 months. Percent of adults diagnosed with a new episode of depression who had optimal practitioner contacts for medication management during the acute treatment phase.